• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Abbott Laboratories

Abbott Laboratories

Abbott Laboratories ABT 3 Star

Last Price$47.00Day Change (%)-0.47%
Open Price$47.14Day Change ($)-0.22
Day Range46.67–47.1452-Week Range36.65–47.88

As of Tue 3/3/2015 3:51:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Top 10 Buys and Sells by the Ultimate Stock-Pickers

    A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.

  2. Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

    Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'

  3. Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business

    Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business

  4. Diversifying in a Shrinking World

    Simple formulas for foreign exposure lose luster.

  5. Research and Markets: Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories , Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating

    Research and Markets: Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories , Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating

  6. Compelling Financial Benefit in Valeant's Latest Buy

    The proposed Salix acquisition boosts our fair value estimate significantly.

  7. Research and Markets: In Vitro Diagnostics (POC/Rapid diagnostics) Global Market - Forecast to 2020

    Research and Markets: In Vitro Diagnostics (POC/Rapid diagnostics) Global Market - Forecast to 2020

  8. Bad Investor Behavior: Overemphasizing Experience

    Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...

  9. Research and Markets: Cardiac Marker Diagnostic Testing Markets 2015

    Research and Markets: Cardiac Marker Diagnostic Testing Markets 2015

  10. Research and Markets: $173 Billion Wearable Technology Market Report 2015-2020 - Analysis of 221 Companies Offering 132 Different Wearable Technology Products

    Research and Markets: $173 Billion Wearable Technology Market Report 2015-2020 - Analysis of 221 Companies Offering 132 Different Wearable Technology Products

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.